Clinical Studies Sponsored by Arrowhead Pharmaceuticals

Phase Study of Plozasiran in Adults With Severe Hypertriglyceridemia

Phase 3 Study of Plozasiran in Adults With Severe Hypertriglyceridemia

Study of ARO-ATXN2 Injection in Adults With Spinocerebellar Ataxia Type 2

Phase 3 Study of Plozasiran in Adults With Hypertriglyceridemia

A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Negative, Chronic Hepatitis B Virus (HBV) Infection

Extension Study of the Safety and Efficacy of Multi-dose Intravenous ARC-520 in Patients With Chronic Hepatitis B (HBV) Infection

Study of ARO-AAT in Normal Adult Volunteers

Study of ARO-APOC3 in Adults With Familial Chylomicronemia Syndrome (FCS)

Study of ARO-CFB in Adult Healthy Volunteers and Patients With Complement-Mediated Kidney Disease

Study of ARO-DUX4 in Adult Patients With Facioscapulohumeral Muscular Dystrophy Type 1

Study of ARO-ANG3 in Participants With Homozygous Familial Hypercholesterolemia (HOFH)

Study of ARC-520 in Patient With Chronic Hepatitis B Virus

Study of ARO-HBV in Normal Adult Volunteers and Patients With Hepatitis B Virus (HBV)

Safety, Tolerability and Effect of ARC-AAT Injection on Circulating and Intrahepatic Alpha-1 Antitrypsin Levels

A Study of ARC-AAT in Healthy Volunteer Subjects and Patients With Alpha-1 Antitrypsin Deficiency (AATD)

A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Positive, Chronic Hepatitis B Virus Infection

A Study of ARC-520 at Varying Infusion Rates in Healthy Adult Volunteers

Study of ARO-APOC3 in Healthy Volunteers, Hypertriglyceridemic Patients and Patients With Familial Chylomicronemia Syndrome (FCS)

Study of ARO-HSD in Healthy Volunteers and Patients With Non-Alcoholic Steatohepatitis (NASH) or Suspected NASH

Study of ARO-ANG3 in Healthy Volunteers and in Dyslipidemic Patients

A Multicenter Study to Determine the Depth and Duration of Hepatitis B Surface Antigen (HBsAg) Reduction After Single or Multiple Doses of ARC-520, in Combination With Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection

Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus (HBV)

Study of Fazirsiran (TAK-999, ARO-AAT) in Patients With Alpha-1 Antitrypsin Deficiency Associated Liver Disease (AATD)

Study of ARO-ANG3 in Adults With Mixed Dyslipidemia

Study of ARO-ENaC in Healthy Volunteers and in Patients With Cystic Fibrosis